Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 48 out of 100. Biomarkers

Topic: Brain proteins, microglia and lab models

Plain-language summary

Background and ObjectivesPlasma phosphorylated tau at threonine 217 (p-Tau217) has demonstrated high diagnostic accuracy for Alzheimer disease (AD), yet most validation studies have been conducted in predominantly non-Hispanic White (NHW) cohorts. Older age was associated with greater odds of abnormal p-Tau217 (odds ratio [OR] 1.08 per year, 95% CI 1.07–1.09), as was APOE ε4 carrier status (OR 3.32, 95% CI 2.65–4.17). Lower eGFR was independently associated with abnormal p-Tau217 (OR 0.97 per unit, 95% CI 0.96–0.97). After adjustment, NHB participants had lower odds of abnormal p-Tau217 than NHW participants (OR 0.61, 95% CI 0.45–0.82), while the association for Hispanic participants was attenuated (OR 0.76, 95% CI 0.56–1.03). Abnormal p-Tau217 was associated with higher odds of clinical cognitive impairment (OR 2.19, 95% CI 1.74–2.76).

What this study adds

Evidence grade: Moderate

This is a cross-sectional study of 2,798 participants. In a diverse cohort, older age and APOE ε4 carrier status were associated with higher odds of abnormal plasma p-Tau217, while Black participants had lower odds than non-Hispanic White participants after adjustment. Reported effect size: OR 3.32; OR 0.97; OR 0.61.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Contreras, J. A., Najmi, Z., Dharmapuri, A., Winston, C. N., Hayes, C. A., & as the HABS-HD Study Team. (2026). Age-Related Prevalence of Abnormal Plasma p-Tau217 Across Racial Ethnic Groups in the Health and Aging Brain Study-Health Disparities. Neurology Open Access. https://doi.org/10.1212/wn9.0000000000000145

Vancouver

Contreras JA, Najmi Z, Dharmapuri A, Winston CN, Hayes CA, as the HABS-HD Study Team. Age-Related Prevalence of Abnormal Plasma p-Tau217 Across Racial Ethnic Groups in the Health and Aging Brain Study-Health Disparities. Neurology Open Access. 2026. doi:10.1212/wn9.0000000000000145.

BibTeX

@article{contreras2026-2e7b0be9,
  author  = {Contreras, Joey Annette and Najmi, Zara and Dharmapuri, Anhiti and Winston, Charisse N. and Hayes, Cellas A. and {as the HABS-HD Study Team}},
  title   = {{Age-Related Prevalence of Abnormal Plasma p-Tau217 Across Racial Ethnic Groups in the Health and Aging Brain Study-Health Disparities}},
  journal = {Neurology Open Access},
  year    = {2026},
  doi     = {10.1212/wn9.0000000000000145},
  url     = {https://doi.org/10.1212/wn9.0000000000000145}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

In a diverse cohort, older age and APOE ε4 carrier status were associated with higher odds of abnormal plasma p-Tau217, while Black participants had lower odds than non-Hispanic White participants after adjustment. Abnormal p-Tau217 was associated with higher odds of clinical cognitive impairment, highlighting the need to consider race and ethnicity in biomarker interpretation.

Study details

How this study scored 48/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 4 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 3 of 4; Effect reported 3 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record left out, no data; Institution's track record 3 of 3; Multicenter collaboration 2 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. 46 of the 96 points it could be judged on, which is 48 of 100. Total 48 of 100.46 of the 96 points we could judge = 48 of 100

Published in a peer-reviewed journal, and it is a snapshot of people at one point in time. Scored zero for randomized / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 46 of the 96 points we could judge it on, which is 48 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Neurology Open Access)
Journal's citation record 0 / 4 Neurology Open Access: journal h-index 5 (OpenAlex, 2026-10-29)
Study design 4 / 12 A snapshot of people at one point in time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 3 / 4 2,798 participants
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 OpenAlex's profile for last-listed author as the HABS-HD Study Team holds only 1 work(s), too few to judge a track record — left out of this score
Institution's track record 3 / 3 Stanford University: institution h-index 2,684 (OpenAlex)
Multicenter collaboration 2 / 3 OpenAlex lists 6 institution(s) in 1 country
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Points 46 / 96 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 46 of the 96 points we could judge it on is 48 out of 100.
Total 48 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 14.

Related studies in Biomarkers from nearby years

Also tagged “phosphorylated”

732 studies in the library carry the topic tag “phosphorylated”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 732 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Biomarkers

See all studies in Biomarkers →